HOME >> MEDICINE >> NEWS
Q Chip helps make cures more effective

Cancer and fibroid treatments are likely to be early beneficiaries of Q Chip's work. Chief Executive Mark Barry is available to discuss the company's technology, which was spun out of research carried out at Cardiff University.

Q Chip is collaborating with Biocompatibles International, a medical device company that is focused on the treatment of cardiovascular disease, cancer and benign tumors to develop its next generation of microspheres. These would allow the effective delivery of drugs to targeted parts of the body.

Q Chip makes its uniform particles using tiny capillaries etched in wafers to precisely create micro and nanoparticles. The key advantage of Q Chip's technology is that it can be very accurate about the size, shape and composition of the particles it makes. Using many of these wafers in tandem, it can create particles on a commercial scale and avoid high levels of waste associated with other production techniques. Berry says that other production techniques involve "throwing away a massive amount of waste."

Q Chip's microparticles can also be precision loaded with drugs. "Precision and sophistication is what we offer," says Berry.


'"/>

Contact: Makeda Scott
makeda.scott@fco.gov.uk
202-588-6523
British Information Services
6-Apr-2005


Page: 1

Related medicine news :

1. Device helps physically disabled turn on computer
2. Case study: cross-cultural bioethics training program helps fight African brain drain
3. New drug development facility helps move medicines to market
4. Research shows aerobic exercise helps maintain muscle in elderly
5. Virtual autopsy helps identify drowning as cause of death
6. Topical retinol helps reduce wrinkles associated with natural skin aging
7. Transplanting human gut bugs into mice helps understanding of metabolic system
8. Quick, innovative procedure helps men minimize incontinence after prostatectomy
9. New research helps overcome major CPAP problem
10. MS drug helps reduce vision loss
11. Strong marriage helps couples deal with tempermental baby

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... September 26, 2017 , ... Ron Norman, CEO of ... use the Law of Large Numbers in favor of senior, upper-level executive job candidates ... casinos, have long understood the Law of Large Numbers as a way of protecting ...
(Date:9/26/2017)... ... September 26, 2017 , ... CGL Electronic Security Inc., an ... its new umbrella, CGL Technologies, LLC. , The new CGL Technologies, LLC office is ... and Jon McCormack, both of whom have creative business development methods, who are responsive ...
(Date:9/26/2017)... Galloway, N.J. (PRWEB) , ... September 26, 2017 ... ... mocktail at the shore, the John R. Elliott HERO Campaign for Designated Drivers ... Hotel & Golf Club. , Thirty-one local bars and restaurants took on the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... Founded as ... decades growing into an innovative leader in special education. In 2018, Glenholme will ... , Glenholme, formerly a world renowned horse farm for Hackney show ponies, was generously ...
(Date:9/26/2017)... ... September 26, 2017 , ... The 2017 American Academy of Cosmetic Surgery ... Fat,” revealed not only the latest about cosmetic procedures to remove and replace fat, ... cosmetic medicine. , “Fat really is magical, especially when it comes to the cosmetic ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... Sapheneia and Scannerside received FDA 510(k) clearance ... a third-party Vendor neutral CT product that makes it ... with current MITA standards. ... is specifically designed to provide CT operators, prior to ... over a predefined threshold. Scannerside Dose Check is intended ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a leading ... a vibrant charitable donation program -- "Color for ... congenital heart defect research by The Children,s Heart ... the general public are encouraged to download a ... the completed artwork to the gallery on the ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology:
Cached News: